AI assistant
HERBALIFE LTD. — Director's Dealing 2020
Dec 7, 2020
32337_dirs_2020-12-07_6d199442-5faf-46be-8361-518ac7fe9e86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE NUTRITION LTD. (HLF)
CIK: 0001180262
Period of Report: 2020-12-03
Reporting Person: Hienrich Edi (SVP/Managing Director EMEA)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-03 | Common Stock | M | 15000 | $23.90 | Acquired | 48529 | Direct |
| 2020-12-03 | Common Stock | F | 10872 | $49.72 | Disposed | 37657 | Direct |
| 2020-12-03 | Common Stock | M | 26872 | $31.255 | Acquired | 64529 | Direct |
| 2020-12-03 | Common Stock | F | 21584 | $49.72 | Disposed | 42945 | Direct |
| 2020-12-04 | Common Stock | S | 6241 | $49.88 | Disposed | 36704 | Direct |
| 2020-12-07 | Common Stock | S | 9416 | $49.8756 | Disposed | 27288 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-03 | Stock Appreciation Rights | $23.90 | M | 15000 | Disposed | 2025-05-07 | Common Stock (15000) | Direct |
| 2020-12-03 | Stock Appreciation Rights | $31.255 | M | 26872 | Disposed | 2026-05-09 | Common Stock (26872) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13819 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $49.87 to $49.88. The price reported reflects the weighted average sale price of $49.8756. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as part of an award covering 12,500 shares at an exercise price of $47.80 per share.
F3: The SARs were granted on May 7, 2015. 20% vested on May 7, 2016, 20% vested on May 7, 2017 and the remaining 60% vested on May 7, 2018.
F4: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as part of an award covering 16,795 shares at an exercise price of $62.51 per share.
F5: The SARs were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019.